President Jimmy Carter’s cancer remission was wonderful news, but as some outlets [1] noted, it is important to understand that not all patients are responding as well to similar treatments, and that there is currently still no “cure” for cancer.
Antibody Basics: Hybridoma
Hybridoma Development Hybridoma technology is the core technique used to develop monoclonal antibodies at ProSci. A hybridoma is a single cell that consists of a cancerous myeloma cell and an immune B-cell which have been fused together into a single
Albumin Removal from Sample Preparations
Biotech Support Group bring you two alternate strategies for albumin removal from sample preparations: AlbuSorb – an albumin binding strategy AlbuVoid – an albumin voiding strategy plus Albutrial, a combined trial kit including 1 gm of AlbuSorb™ and 5 Preps of AlbuVoid™ with
Lipid Removal and Clarification
The Cleanascite™ reagent has been used extensively across a number of research applications to selectively removes lipids and their constituents (e.g cell debris, transgenic milk and egg yolk) for pretreatment of samples prior to purification. The reagent is a solid-phase,
The Fas and the Furious: 7 Facts to Catch You Up to Speed on Fas and How a Fas Antibody Can Help Your Research
Fas antigen is a receptor protein that has been linked to many diseases such as cancer(1) and autoimmune diseases(2). Here are seven findings from research on this protein to catch you up to speed on Fas: Fas is mainly involved
Give Your Research 100% With a S100 Antibody
S100 proteins are a family of proteins known for their role in a variety of cellular pathways and diseases. This blog post will catch you up on the latest research on these important proteins. The S100 protein family consists of
Elevate your Cholesterol Research Part 2: How Our PCSK9 ELISA Kit Can Help You
As discussed in a previous blog post, inhibiting PCSK9 from binding to the LDL receptor results in lower LDL cholesterol levels in the bloodstream. Research on PCSK9 has explored how it can be targeted in treatments for hypercholesterolemia (high cholesterol)
Immunostaining of Circulating Tumour Cells in TransFix Stabilised Blood Samples
The presence of circulating tumour cells (CTC’s) has been shown to be of diagnostic relevance for patients with early and advanced breast cancer (BC). The usefulness of CTC assessments depends upon accurate cell counts and the corresponding analysis of molecular
The Ubiquitin-Proteasome System
The UPS and the autophagic-lysosomal pathway are the two major degradation systems for native & misfolded proteins in eukaryotic cells.
Small Molecules: Product Highlights
Caltag Medsystems have a vast portfolio of compounds for research – including inhibitors, biochemicals, small molecules, lipids and antibiotics. To view our full range of compounds, please click here. Alternatively, if you know what you are looking for, you can